FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033874197> ?p ?o ?g. }

• W3033874197 endingPage "1217" @default.
• W3033874197 startingPage "1206" @default.
• W3033874197 abstract "Direct‐acting antiviral therapies (DAAs) may improve kidney function and proteinuria in certain patients with hepatitis C infection (HCV) and chronic kidney disease (CKD). To improve our understanding of HCV‐mediated kidney dysfunction, we aimed to evaluate the baseline predictors of improvement in proteinuria after DAAs in a single‐arm, pilot, clinical trial of ledipasvir 90 mg/sofosbuvir 400 mg once daily for patients with HCV genotype 1 or 4 infection and proteinuric CKD (≥300 mg proteinuria per gram creatinine). Plasma biomarkers of complement system (C3 and C4) and urinary kidney injury biomarkers were measured at baseline, 8 weeks on treatment, 12 weeks following treatment, and 1 year following treatment. We then conducted a retrospective cohort study of patients at Partners Healthcare who had baseline complement component 4 (C4) measured before DAAs for HCV and evaluated the change in estimated glomerular filtration rate (eGFR) before and after therapy. Ten patients with HCV and proteinuric CKD were enrolled in the trial. The mean age was 64 years, 70% male, 70% white, and 30% black. Baseline creatinine was 1.25 mg/dL (SD 0.44), eGFR was 65 mL/min/1.73 m2 (SD 29), and proteinuria was 0.98 g/g creatinine (SD 0.7). Sustained virologic response at 12 weeks was achieved by 80% of patients. Patients with low baseline C4 had improved proteinuria, urinary neutrophil gelatinase‐associated lipocalin, and interleukin‐18 after ledipasvir and sofosbuvir treatment. The retrospective study included 50 patients with CKD and HCV. Twenty patients (40%) had low baseline C4; these patients significantly improved their eGFR (+3.4 ± 11.2 mL/min/1.73 m2) compared to those with normal baseline C4 (−4.4 ± 12.2 mL/min/1.73 m2; P = 0.028). Conclusion: Low C4 may be a marker of kidney dysfunction that improves with DAA therapy." @default.
• W3033874197 created "2020-06-12" @default.
• W3033874197 creator A5020069661 @default.
• W3033874197 creator A5024249330 @default.
• W3033874197 creator A5048669465 @default.
• W3033874197 creator A5050023158 @default.
• W3033874197 creator A5051178808 @default.
• W3033874197 creator A5053149768 @default.
• W3033874197 creator A5064518665 @default.
• W3033874197 creator A5079203561 @default.
• W3033874197 date "2020-06-04" @default.
• W3033874197 modified "2023-10-04" @default.
• W3033874197 title "Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus" @default.
• W3033874197 cites W1908153784 @default.
• W3033874197 cites W1979961218 @default.
• W3033874197 cites W2047859692 @default.
• W3033874197 cites W2063889780 @default.
• W3033874197 cites W2086388926 @default.
• W3033874197 cites W2110280174 @default.
• W3033874197 cites W2138339906 @default.
• W3033874197 cites W2153329470 @default.
• W3033874197 cites W2155965977 @default.
• W3033874197 cites W2217275225 @default.
• W3033874197 cites W2593373391 @default.
• W3033874197 cites W2743195255 @default.
• W3033874197 cites W2750695533 @default.
• W3033874197 cites W2761085897 @default.
• W3033874197 cites W2944896029 @default.
• W3033874197 cites W2950823694 @default.
• W3033874197 doi "https://doi.org/10.1002/hep4.1528" @default.
• W3033874197 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7395066" @default.
• W3033874197 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32766479" @default.
• W3033874197 hasPublicationYear "2020" @default.
• W3033874197 type Work @default.
• W3033874197 sameAs 3033874197 @default.
• W3033874197 citedByCount "2" @default.
• W3033874197 countsByYear W30338741972021 @default.
• W3033874197 countsByYear W30338741972023 @default.
• W3033874197 crossrefType "journal-article" @default.
• W3033874197 hasAuthorship W3033874197A5020069661 @default.
• W3033874197 hasAuthorship W3033874197A5024249330 @default.
• W3033874197 hasAuthorship W3033874197A5048669465 @default.
• W3033874197 hasAuthorship W3033874197A5050023158 @default.
• W3033874197 hasAuthorship W3033874197A5051178808 @default.
• W3033874197 hasAuthorship W3033874197A5053149768 @default.
• W3033874197 hasAuthorship W3033874197A5064518665 @default.
• W3033874197 hasAuthorship W3033874197A5079203561 @default.
• W3033874197 hasBestOaLocation W30338741971 @default.
• W3033874197 hasConcept C126322002 @default.
• W3033874197 hasConcept C126894567 @default.
• W3033874197 hasConcept C159641895 @default.
• W3033874197 hasConcept C203014093 @default.
• W3033874197 hasConcept C2522874641 @default.
• W3033874197 hasConcept C2776408679 @default.
• W3033874197 hasConcept C2776455275 @default.
• W3033874197 hasConcept C2778390639 @default.
• W3033874197 hasConcept C2778653478 @default.
• W3033874197 hasConcept C2779561371 @default.
• W3033874197 hasConcept C2780040827 @default.
• W3033874197 hasConcept C2780091579 @default.
• W3033874197 hasConcept C2780306776 @default.
• W3033874197 hasConcept C71924100 @default.
• W3033874197 hasConcept C90924648 @default.
• W3033874197 hasConceptScore W3033874197C126322002 @default.
• W3033874197 hasConceptScore W3033874197C126894567 @default.
• W3033874197 hasConceptScore W3033874197C159641895 @default.
• W3033874197 hasConceptScore W3033874197C203014093 @default.
• W3033874197 hasConceptScore W3033874197C2522874641 @default.
• W3033874197 hasConceptScore W3033874197C2776408679 @default.
• W3033874197 hasConceptScore W3033874197C2776455275 @default.
• W3033874197 hasConceptScore W3033874197C2778390639 @default.
• W3033874197 hasConceptScore W3033874197C2778653478 @default.
• W3033874197 hasConceptScore W3033874197C2779561371 @default.
• W3033874197 hasConceptScore W3033874197C2780040827 @default.
• W3033874197 hasConceptScore W3033874197C2780091579 @default.
• W3033874197 hasConceptScore W3033874197C2780306776 @default.
• W3033874197 hasConceptScore W3033874197C71924100 @default.
• W3033874197 hasConceptScore W3033874197C90924648 @default.
• W3033874197 hasIssue "8" @default.
• W3033874197 hasLocation W30338741971 @default.
• W3033874197 hasLocation W30338741972 @default.
• W3033874197 hasLocation W30338741973 @default.
• W3033874197 hasOpenAccess W3033874197 @default.
• W3033874197 hasPrimaryLocation W30338741971 @default.
• W3033874197 hasRelatedWork W2124543160 @default.
• W3033874197 hasRelatedWork W2129198067 @default.
• W3033874197 hasRelatedWork W2140445493 @default.
• W3033874197 hasRelatedWork W2184243264 @default.
• W3033874197 hasRelatedWork W2916219914 @default.
• W3033874197 hasRelatedWork W3011378569 @default.
• W3033874197 hasRelatedWork W3133946270 @default.
• W3033874197 hasRelatedWork W3148712325 @default.
• W3033874197 hasRelatedWork W4280508227 @default.
• W3033874197 hasRelatedWork W593504957 @default.
• W3033874197 hasVolume "4" @default.
• W3033874197 isParatext "false" @default.
• W3033874197 isRetracted "false" @default.
• W3033874197 magId "3033874197" @default.

• next